Target intelligence / Profile preview

RN7SK pseudogene 232 (RN7SKP232)

Target
RN7SKP232
Molecular classification
Other (Pseudogene; Non-coding RNA pseudogene)
01

Overview

RN7SK pseudogene 232 is a genomic DNA sequence homologous to the functional 7SK small nuclear RNA gene but is classified as a pseudogene, meaning it does not encode a functional product and is not known to participate in any canonical biological processes[1]. The functional 7SK RNA plays a critical regulatory role in transcription by modulating the activity of the positive transcription elongation factor P-TEFb, specifically by sequestering its kinase activity and interacting with associated protein complexes[2][3]. Pseudogenes such as RN7SKP232 arise through genomic duplication or retrotransposition events, but they typically lack the regulatory sequences or structures required to produce functional RNA, and thus do not serve as therapeutic targets, receptors, enzymes, or other classical druggable biomolecules. RN7SKP232 is not a therapeutic target and does not encode a functional molecule. There is nothing inherently therapeutic or actionable about this pseudogene, nor any established biomarker, disease association, interacting drug, or safety concern linked specifically to RN7SKP232 or other RN7SK pseudogenes[1]. The functional gene 7SK (not this pseudogene) is a well-studied non-coding RNA, integrally involved in transcriptional regulation, especially in neuronal biology[2].

Other names
RNA, 7SK small nuclear pseudogene 232RN7SKP232RN7SK pseudogene 2327SK pseudogene

Beyond the preview

Go deeper on RN7SK pseudogene 232 (RN7SKP232).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 232 (RN7SKP232).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call